Phase 0 1 trial
Phase 0
NCT03568994 Background Jul 2018 → Sep 2020 acute myeloid leukemia Baylor College of Medicine
Completed
No outcome recorded
Phase 1 34 trials
Phase 1
NCT07052994 Background May 2026 childhood leukemia M.D. Anderson Cancer Center
Withdrawn
No outcome recorded
Phase 1
NCT06313437 Background Dec 2024 → Mar 2027 expected acute myeloid leukemia Dana-Farber Cancer Institute
Recruiting
No outcome recorded
Phase 1
NCT05886049 Background Jun 2024 → Dec 2027 expected acute myeloid leukemia with mutated NPM1 , acute myeloid leukemia, MLL gene rearrangement National Cancer Institute (NCI)
Recruiting
No outcome recorded
Phase 1
NCT06226571 Background May 2024 → Feb 2027 expected acute myeloid leukemia Syndax Pharmaceuticals
Active not recruiting
No outcome recorded
Phase 1
NCT05735184 Background Jul 2023 → Apr 2030 expected acute myeloid leukemia with mutated NPM1 , acute myeloid leukemia, MLL gene rearrangement , myeloid sarcoma Kura Oncology, Inc.
Recruiting
No outcome recorded
Phase 1
NCT03962465 Background Jul 2022 → Jul 2023 overdue B-cell acute lymphoblastic leukemia University of Virginia
Active not recruiting
No outcome recorded
Phase 1
NCT05157971 Background Mar 2022 → Apr 2027 expected B-lymphoblastic leukemia/lymphoma, BCR-ABL1–like City of Hope Medical Center
Active not recruiting
No outcome recorded
Phase 1
NCT05326516 Background Mar 2022 → Jul 2024 acute lymphoblastic leukemia , acute undifferentiated leukemia , mixed phenotype acute leukemia Syndax Pharmaceuticals
Completed
No outcome recorded
Phase 1
NCT04659616 Background Jan 2021 → Dec 2026 expected acute myeloid leukemia OHSU Knight Cancer Institute
Recruiting
No outcome recorded
Phase 1
NCT03900949 Background Mar 2019 → Aug 2024 acute myeloid leukemia Uma Borate
Completed
No outcome recorded
Phase 1
NCT03709758 Background Oct 2018 → Feb 2025 overdue acute myeloid leukemia Dana-Farber Cancer Institute
Active not recruiting
No outcome recorded
Phase 1
NCT03444649 Background Sep 2018 → Aug 2019 acute myeloid leukemia Insel Gruppe AG, University Hospital Bern
Withdrawn
No outcome recorded
Phase 1
NCT03563560 Background May 2018 → Mar 2020 acute myeloid leukemia Sumitomo Pharma Co., Ltd.
Completed
No outcome recorded
Phase 1
NCT03298984 Background Sep 2017 → Mar 2020 acute myeloid leukemia Sumitomo Pharma America, Inc.
Completed
No outcome recorded
Phase 1
NCT03135028 Background May 2017 → Feb 2019 acute myeloid leukemia Gilead Sciences
Terminated
No outcome recorded
Phase 1
NCT02954653 Comparator Nov 2016 → Dec 2017 acute myeloid leukemia Pfizer
Terminated
No outcome recorded
Phase 1
NCT02834390 Background Aug 2016 → Oct 2017 acute myeloid leukemia Daiichi Sankyo
Completed
No outcome recorded
Phase 1
NCT02582359 Background Jan 2016 → Apr 2022 acute myeloid leukemia Massachusetts General Hospital
Completed
No outcome recorded
Phase 1
NCT02403310 Background Jun 2015 → Sep 2016 acute myeloid leukemia by FAB classification H. Lee Moffitt Cancer Center and Research Institute
Completed
No outcome recorded
Phase 1
NCT02303821 Background Feb 2015 → Jun 2024 acute lymphoblastic leukemia Amgen
Completed
No outcome recorded
Phase 1
NCT02326584 Background Dec 2014 → Jan 2017 acute myeloid leukemia Seagen Inc.
Completed
No outcome recorded
Phase 1
NCT02038777 Background Mar 2014 → Feb 2021 acute myeloid leukemia Pfizer
Completed
No outcome recorded
Phase 1
NCT02029950 Background Dec 2013 → May 2020 acute myeloid leukemia , chronic myelomonocytic leukemia , myelodysplastic syndrome National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT01773408 Background Feb 2013 → Jun 2016 acute myeloid leukemia Hoffmann-La Roche
Completed
No outcome recorded
Phase 1
NCT01455025 Background Jan 2012 → Mar 2015 acute myeloid leukemia French Innovative Leukemia Organisation
Terminated
No outcome recorded
Phase 1
NCT01463046 Background Jan 2012 → Nov 2015 acute myeloid leukemia , myelodysplastic syndrome University of California, San Francisco
Completed
No outcome recorded
Phase 1
NCT01390337 Background Oct 2011 → Feb 2015 acute myeloid leukemia Daiichi Sankyo
Completed
No outcome recorded
Phase 1
NCT01265199 Background Feb 2011 → Jan 2013 acute myeloid leukemia Ascenta Therapeutics
Terminated
No outcome recorded
Phase 1
NCT00866307 Background Feb 2009 → Jun 2014 B-cell adult acute lymphocytic leukemia , B-cell childhood acute lymphoblastic leukemia Children's Oncology Group
Completed
No outcome recorded
Phase 1
NCT00544999 Background Sep 2007 → Apr 2010 leukemia Institut de Recherche Clinique sur les Cancers et le Sang
Unknown
No outcome recorded
Phase 1
NCT00101153 Background Apr 2007 → Mar 2010 leukemia University Health Network, Toronto
Completed
No outcome recorded
Phase 1
NCT00124644 Background Mar 2006 → Dec 2007 leukemia Ohio State University Comprehensive Cancer Center
Terminated
No outcome recorded
Phase 1
NCT00093600 Background Feb 2004 → Jun 2011 acute myeloid leukemia Novartis Pharmaceuticals
Completed
No outcome recorded
Phase 1
NCT00268229 Background Jul 2003 → Aug 2011 leukemia The Cleveland Clinic
Completed
No outcome recorded
Show 29 more trials Phase 1/2 17 trials
Phase 1/2
NCT07585734 Background Apr 2025 → Apr 2026 T-cell acute lymphoblastic leukemia Institute of Hematology & Blood Diseases Hospital, China
Withdrawn
No outcome recorded
Phase 1/2
NCT06746519 Background Dec 2024 → Dec 2025 overdue acute myeloid leukemia Chen Suning
Recruiting
No outcome recorded
Phase 1/2
NCT04988555 Background Feb 2022 → Jun 2027 expected acute lymphoblastic leukemia , acute myeloid leukemia , myelodysplastic syndrome , plasma cell myeloma Sumitomo Pharma America, Inc.
Recruiting
No outcome recorded
Phase 1/2
NCT04817241 Comparator Feb 2022 → Jun 2025 overdue acute myeloid leukemia National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 1/2
NCT05445154 Background Aug 2021 → Oct 2024 overdue acute myeloid leukemia CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Recruiting
No outcome recorded
Phase 1/2
NCT04501614 Background Feb 2021 → Dec 2023 B-lymphoblastic leukemia/lymphoma, BCR-ABL1–like , childhood acute lymphoblastic leukemia , mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2) Takeda
Terminated
No outcome recorded
Phase 1/2
NCT04385290 Background Sep 2020 → Apr 2027 expected acute myeloid leukemia Technical University Dresden
Recruiting
No outcome recorded
Phase 1/2
NCT03760445 Background Nov 2019 → Jul 2021 acute myeloid leukemia Novartis Pharmaceuticals
Withdrawn
No outcome recorded
Phase 1/2
NCT03724084 Background Apr 2019 → Nov 2022 acute myeloid leukemia National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 1/2
NCT02472626 Background Dec 2015 → Jul 2016 acute myeloid leukemia Wake Forest University Health Sciences
Withdrawn
No outcome recorded
Phase 1/2
NCT02343939 Background Jul 2015 → Sep 2018 acute myeloid leukemia Gilead Sciences
Terminated
No outcome recorded
Phase 1/2
NCT00850382 Background Jun 2009 → Nov 2015 acute myeloid leukemia University of Ulm
Completed
No outcome recorded
Phase 1/2
NCT00840684 Background Jan 2009 → May 2011 leukemia Institut Paoli-Calmettes
Completed
No outcome recorded
Phase 1/2
NCT00742625 Background Sep 2008 → Jul 2010 acute erythroid leukemia , acute megakaryoblastic leukemia in adult , acute myeloblastic leukemia with maturation , acute myeloblastic leukemia without maturation +5 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1/2
NCT00129168 Background Aug 2005 → Mar 2008 myeloid leukemia Kanisa Pharmaceuticals
Completed
No outcome recorded
Phase 1/2
NCT00061945 Background Jun 2003 → Dec 2007 B-cell adult acute lymphocytic leukemia , B-cell childhood acute lymphoblastic leukemia , T-cell adult acute lymphocytic leukemia , T-cell childhood acute lymphocytic leukemia +1 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1/2
NCT00005942 Background Mar → Dec 2000 acute myeloid leukemia , chronic myelomonocytic leukemia , myelodysplastic syndrome with excess blasts , refractory anemia with excess blasts in transformation National Cancer Institute (NCI)
Completed
No outcome recorded
Show 12 more trials Phase 2 68 trials
Phase 2
NCT07636564 Background Oct 2026 → Apr 2031 expected B-cell acute lymphoblastic leukemia , T-cell acute lymphoblastic leukemia , acute leukemia of ambiguous lineage SWOG Cancer Research Network
Not yet recruiting
No outcome recorded
Phase 2
NCT07664839 Comparator Jul 2026 → May 2028 expected acute myeloid leukemia with mutated NPM1 Shen yang
Not yet recruiting
No outcome recorded
Phase 2
NCT07228273 Comparator Dec 2025 → Jun 2029 expected acute myeloid leukemia , myelodysplastic syndrome OHSU Knight Cancer Institute
Recruiting
No outcome recorded
Phase 2
NCT06918431 Background Oct 2025 → Mar 2029 expected B-cell acute lymphoblastic leukemia , lymphoblastic lymphoma City of Hope Medical Center
Recruiting
No outcome recorded
Phase 2
NCT07512700 Comparator Sep 2025 → Sep 2028 expected acute monocytic leukemia Chinese PLA General Hospital
Recruiting
No outcome recorded
Phase 2
NCT06317662 Background Jun 2025 → Dec 2028 expected B-cell acute lymphoblastic leukemia , acute leukemia of ambiguous lineage National Cancer Institute (NCI)
Recruiting
No outcome recorded
Phase 2
NCT06124157 Background May 2025 → Dec 2030 expected B-cell acute lymphoblastic leukemia National Cancer Institute (NCI)
Recruiting
No outcome recorded
Phase 2
NCT06533748 Background Jan 2025 → May 2028 expected lymphoblastic lymphoma , precursor B-cell acute lymphoblastic leukemia St. Jude Children's Research Hospital
Recruiting
No outcome recorded
Phase 2
NCT06744556 Comparator Jan 2025 → Dec 2027 expected acute myeloid leukemia Institute of Hematology & Blood Diseases Hospital, China
Active not recruiting
No outcome recorded
Phase 2
NCT06390319 Background Dec 2024 → Dec 2027 expected T-cell acute lymphoblastic leukemia , T-cell non-Hodgkin lymphoma , mixed phenotype acute leukemia St. Jude Children's Research Hospital
Recruiting
No outcome recorded
Phase 2
NCT07514936 Comparator Nov 2024 → Sep 2027 expected acute myeloid leukemia Chinese PLA General Hospital
Recruiting
No outcome recorded
Phase 2
NCT06497062 Background Oct 2024 → Oct 2027 expected acute myeloid leukemia Shanghai Jiao Tong University School of Medicine
Active not recruiting
No outcome recorded
Phase 2
NCT06635681 Background Sep 2024 → Dec 2026 expected acute myeloid leukemia Institute of Hematology & Blood Diseases Hospital, China
Recruiting
No outcome recorded
Phase 2
NCT06451861 Comparator Aug 2024 → Dec 2026 expected acute myeloid leukemia Guangdong Provincial People's Hospital
Recruiting
No outcome recorded
Phase 2
NCT06210750 Background Aug 2024 → Sep 2026 T-cell acute lymphoblastic leukemia , T-lymphoblastic lymphoma National Cancer Institute (NCI)
Withdrawn
No outcome recorded
Phase 2
NCT06928376 Comparator Apr 2024 → Sep 2025 overdue acute myeloid leukemia Chinese PLA General Hospital
Recruiting
No outcome recorded
Phase 2
NCT06262438 Background Feb 2024 → Jun 2028 expected childhood acute myeloid leukemia Princess Maxima Center for Pediatric Oncology
Recruiting
No outcome recorded
Phase 2
NCT06084819 Comparator Aug 2023 → Jan 2029 expected acute myeloid leukemia Chinese PLA General Hospital
Recruiting
No outcome recorded
Phase 2
NCT05955261 Background Jul 2023 → Dec 2026 acute myeloid leukemia St. Jude Children's Research Hospital
Suspended
No outcome recorded
Phase 2
NCT06068621 Comparator Mar 2023 → May 2024 acute myeloid leukemia Chinese PLA General Hospital
Completed
No outcome recorded
Phase 2
NCT05660473 Background Aug 2022 → Dec 2027 expected precursor lymphoblastic lymphoma/leukemia Institute of Hematology & Blood Diseases Hospital, China
Recruiting
No outcome recorded
Phase 2
NCT05361057 Comparator Jun 2022 → Feb 2023 acute myeloid leukemia Institute of Hematology & Blood Diseases Hospital, China
Terminated
No outcome recorded
Phase 2
NCT04214249 Background Feb 2021 → Nov 2024 overdue therapy related acute myeloid leukemia and myelodysplastic syndrome National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 2
NCT04687176 Background Jan 2021 → Dec 2025 overdue acute promyelocytic leukemia The University of Hong Kong
Recruiting
No outcome recorded
Phase 2
NCT04440267 Background Jul 2020 → Jun 2026 overdue acute leukemia of ambiguous lineage Institute of Hematology & Blood Diseases Hospital, China
Recruiting
No outcome recorded
Phase 2
NCT03836209 Background Dec 2019 → Oct 2023 overdue acute myeloid leukemia PrECOG, LLC.
Active not recruiting
No outcome recorded
Phase 2
NCT03860844 Background Aug 2019 → Sep 2022 acute lymphoblastic leukemia , acute myeloid leukemia Sanofi
Terminated
No outcome recorded
Phase 2
NCT03591510 Background Mar 2019 → May 2029 expected acute myeloid leukemia Novartis Pharmaceuticals
Active not recruiting
No outcome recorded
Phase 2
NCT02835222 Background Feb 2018 → Feb 2027 expected acute myeloid leukemia Wake Forest University Health Sciences
Active not recruiting
No outcome recorded
Phase 2
NCT03164057 Background Jun 2017 → Sep 2025 overdue acute myeloid leukemia , myelodysplastic syndrome St. Jude Children's Research Hospital
Active not recruiting
No outcome recorded
Phase 2
NCT02828358 Background Apr 2017 → Sep 2020 B-cell acute lymphoblastic leukemia , mixed phenotype acute leukemia National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT02937662 Comparator Oct 2016 → Apr 2020 acute myeloid leukemia Institute of Hematology & Blood Diseases Hospital, China
Completed
No outcome recorded
Phase 2
NCT02776605 Background Jun 2016 → Aug 2020 —
PETHEMA Foundation
Unknown
No outcome recorded
Phase 2
NCT02198482 Background Feb → Nov 2016 acute myeloid leukemia , myelodysplastic syndrome University of Ulm
Terminated
No outcome recorded
Phase 2
NCT02660762 Background Jan 2016 → Jan 2019 acute lymphoblastic leukemia Sun Yat-sen University
Unknown
No outcome recorded
Phase 2
NCT02560025 Background Dec 2015 → Oct 2017 acute myeloid leukemia Massachusetts General Hospital
Completed
No outcome recorded
Phase 2
NCT02523976 Background Aug 2015 → Dec 2021 acute lymphoblastic leukemia Institute of Hematology & Blood Diseases Hospital, China
Completed
No outcome recorded
Phase 2
NCT01890746 Background Sep 2013 → Mar 2015 acute leukemia Novartis Pharmaceuticals
Completed
No outcome recorded
Phase 2
NCT01920737 Background Aug 2013 → Aug 2026 overdue leukemia Memorial Sloan Kettering Cancer Center
Active not recruiting
No outcome recorded
Phase 2
NCT01794169 Comparator Mar 2013 → Sep 2015 acute myeloid leukemia Karolinska University Hospital
Terminated
No outcome recorded
Phase 2
NCT01690065 Background Sep 2012 → Sep 2019 acute myeloid leukemia , blast phase chronic myelogenous leukemia, BCR-ABL1 positive Ulsan University Hospital
Unknown
No outcome recorded
Phase 2
NCT01546038 Background Jun 2012 → Jan 2017 acute myeloid leukemia Pfizer
Completed
No outcome recorded
Phase 2
NCT01477606 Background May 2012 → Feb 2020 acute myeloid leukemia University of Ulm
Completed
No outcome recorded
Phase 2
NCT01349972 Comparator Apr 2011 → May 2014 acute erythroid leukemia , acute myeloblastic leukemia with maturation , acute myeloblastic leukemia without maturation , acute myeloid leukemia with 11q23 abnormalities +8 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01238211 Background Dec 2010 → Jul 2013 acute myeloid leukemia, inv(16)(p13.1;q22) , acute myeloid leukemia, t(16;16)(p13.1;q22) , acute myeloid leukemia, t(8;21)(q22; q22.1) , core binding factor acute myeloid leukemia +1 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01256398 Background Dec 2010 → Nov 2017 B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2) , acute lymphoblastic leukemia National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00943553 Background Jun 2010 → Aug 2011 acute myeloid leukemia Eisai Inc.
Withdrawn
No outcome recorded
Phase 2
NCT01004497 Background Mar 2010 → Apr 2014 acute lymphoblastic leukemia The Catholic University of Korea
Completed
No outcome recorded
Phase 2
NCT00915252 Comparator Jul 2009 → Dec 2012 acute myeloid leukemia University Hospital Muenster
Completed
No outcome recorded
Phase 2
NCT00844298 Background Jan 2009 → Jun 2012 leukemia Asan Medical Center
Completed
No outcome recorded
Phase 2
NCT00788892 Comparator Oct 2008 → Jun 2010 acute myeloid leukemia Jazz Pharmaceuticals
Completed
No outcome recorded
Phase 2
NCT00416598 Background Nov 2006 → Jan 2011 acute myeloid leukemia, inv(16)(p13.1;q22) , acute myeloid leukemia, t(16;16)(p13.1;q22) , acute myeloid leukemia, t(8;21)(q22; q22.1) , acute myeloid leukemia, t(9;11)(p21.3;q23.3) National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00618501 Background Oct 2005 → Dec 2008 leukemia Asan Medical Center
Completed
No outcome recorded
Phase 2
NCT00458848 Background Oct 2004 → Mar 2014 leukemia GIMEMA Foundation
Completed
No outcome recorded
Phase 2
NCT00276601 Background Oct 2004 → Dec 2007 leukemia Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Completed
No outcome recorded
Phase 2
NCT00184041 Background Jul 2004 → Dec 2011 adult acute lymphoblastic leukemia University of Southern California
Completed
No outcome recorded
Phase 2
NCT00195871 Background Feb 2004 → Jun 2014 lymphoblastic lymphoma Centre Henri Becquerel
Unknown
No outcome recorded
Phase 2
NCT00070174 Background Dec 2003 → Sep 2006 leukemia Children's Oncology Group
Completed
No outcome recorded
Phase 2
NCT00022126 Background Nov 2002 → Jan 2005 leukemia Children's Oncology Group
Completed
No outcome recorded
Phase 2
NCT00130195 Background Sep 2002 → Feb 2008 acute lymphoblastic leukemia Japan Adult Leukemia Study Group
Completed
No outcome recorded
Phase 2
NCT00176462 Background Feb 2001 → Sep 2008 acute lymphoblastic leukemia Rutgers, The State University of New Jersey
Completed
No outcome recorded
Phase 2
NCT00004215 Background Aug 1999 → Aug 2000 anemia , leukemia , neutropenia , thrombocytopenia Memorial Sloan Kettering Cancer Center
Completed
No outcome recorded
Phase 2
NCT00002785 Background Jul 1996 → Aug 2000 leukemia Children's Oncology Group
Completed
No outcome recorded
Phase 2
NCT00002756 Background Jun 1996 → Sep 2007 leukemia Children's Oncology Group
Completed
No outcome recorded
Phase 2
NCT00002704 Background Jan 1996 → Jun 2004 leukemia National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00002590 Background Jul 1994 → Mar 2001 lymphoma Children's Oncology Group
Completed
No outcome recorded
Phase 2
NCT00136448 Background Feb 1993 → Sep 2007 acute myeloid leukemia Dana-Farber Cancer Institute
Completed
No outcome recorded
Phase 2
NCT00002471 Background Feb 1990 → Jan 2003 leukemia , lymphoma Memorial Sloan Kettering Cancer Center
Completed
No outcome recorded
Show 63 more trials Phase 2/3 10 trials
Phase 2/3
NCT07072585 Background Aug 2026 → Sep 2035 expected T-cell acute lymphoblastic leukemia , T-lymphoblastic lymphoma Children's Oncology Group
Not yet recruiting
No outcome recorded
Phase 2/3
NCT07255872 Background Mar 2026 → Dec 2027 expected acute myeloid leukemia Sichuan Baili Pharmaceutical Co., Ltd.
Not yet recruiting
No outcome recorded
Phase 2/3
NCT05939180 Comparator Apr 2024 → Oct 2025 overdue acute myeloid leukemia The First Affiliated Hospital of Soochow University
Recruiting
No outcome recorded
Phase 2/3
NCT03701308 Background Mar 2019 → Oct 2024 overdue acute myeloid leukemia National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 2/3
NCT03117751 Background Mar 2017 → Sep 2026 expected lymphoblastic leukemia, acute, with lymphomatous features St. Jude Children's Research Hospital
Active not recruiting
No outcome recorded
Phase 2/3
NCT02416388 Comparator Jan 2015 → Jul 2025 overdue acute myeloid leukemia University Hospital, Angers
Recruiting
No outcome recorded
Phase 2/3
NCT02451774 Comparator Jan 2015 → Dec 2019 childhood acute lymphoblastic leukemia Ramón Óscar González-Ramella, Ph.D
Unknown
No outcome recorded
Phase 2/3
NCT02272478 Comparator Oct 2014 → Feb 2021 acute myeloid leukemia , myelodysplastic syndrome Cardiff University
Unknown
No outcome recorded
Phase 2/3
NCT01228331 Comparator Oct 2010 → Dec 2019 leukemia University Medical Center Hamburg-Eppendorf
Completed
No outcome recorded
Phase 2/3
NCT00720109 Background Jul 2008 → Dec 2014 B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2) , acute lymphoblastic leukemia National Cancer Institute (NCI)
Completed
No outcome recorded
Show 5 more trials Phase 3 74 trials
Phase 3
NCT07407140 Comparator Apr 2026 → Feb 2029 expected acute myeloid leukemia Institute of Hematology & Blood Diseases Hospital, China
Not yet recruiting
No outcome recorded
Phase 3
NCT07223814 Background Mar 2026 → Jun 2030 expected acute myeloid leukemia HOVON Foundation
Recruiting
No outcome recorded
Phase 3
NCT07211958 Background Nov 2025 → Jun 2029 expected acute myeloid leukemia Syndax Pharmaceuticals
Recruiting
No outcome recorded
Phase 3
NCT07007312 Background Sep 2025 → Nov 2031 expected acute myeloid leukemia Kura Oncology, Inc.
Recruiting
No outcome recorded
Phase 3
NCT07132684 Comparator Aug 2025 → Aug 2027 expected acute myeloid leukemia Institute of Hematology & Blood Diseases Hospital, China
Recruiting
No outcome recorded
Phase 3
NCT06713837 Comparator Feb 2025 → Jan 2028 expected acute myeloid leukemia Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Recruiting
No outcome recorded
Phase 3
NCT06744504 Background Jan 2025 → Dec 2027 expected acute myeloid leukemia, t(8;21)(q22; q22.1) Institute of Hematology & Blood Diseases Hospital, China
Recruiting
No outcome recorded
Phase 3
NCT06810791 Comparator Jan 2025 → Jun 2026 overdue acute myeloid leukemia Nanfang Hospital, Southern Medical University
Recruiting
No outcome recorded
Phase 3
NCT06578247 Background Nov 2024 → Jun 2030 expected leukemia Daiichi Sankyo
Active not recruiting
No outcome recorded
Phase 3
NCT06361329 Comparator Apr 2024 → Mar 2026 overdue early T cell progenitor acute lymphoblastic leukemia First Affiliated Hospital of Zhejiang University
Recruiting
No outcome recorded
Phase 3
NCT06345365 Comparator Jan 2024 → Dec 2026 expected acute myeloid leukemia Zhongnan Hospital
Recruiting
No outcome recorded
Phase 3
NCT05681260 Background Feb 2023 → Dec 2026 expected T-lymphoblastic lymphoma Children's Cancer Group, China
Recruiting
No outcome recorded
Phase 3
NCT05726110 Background Jan 2023 → Dec 2024 overdue acute myeloid leukemia Shanxi Bethune Hospital
Recruiting
No outcome recorded
Phase 3
NCT04628026 Background Sep 2022 → Mar 2029 expected acute myeloid leukemia University of Ulm
Recruiting
No outcome recorded
Phase 3
NCT04676243 Background May 2022 → May 2025 acute myeloid leukemia University Hospital Heidelberg
Withdrawn
No outcome recorded
Phase 3
NCT05020665 Background Nov 2021 → Mar 2023 acute myeloid leukemia with mutated NPM1 Kronos Bio
Terminated
No outcome recorded
Phase 3
NCT04778397 Comparator Jul 2021 → Mar 2024 acute myeloid leukemia Gilead Sciences
Terminated
No outcome recorded
Phase 3
NCT04174612 Background Apr 2020 → Dec 2022 acute myeloid leukemia, FLT3 internal tandem duplication GIMEMA Foundation
Unknown
No outcome recorded
Phase 3
NCT03959085 Background Oct 2019 → Mar 2032 expected B-cell acute lymphoblastic leukemia , central nervous system leukemia , lymphoblastic lymphoma , mixed phenotype acute leukemia +1 Children's Oncology Group
Recruiting
No outcome recorded
Phase 3
NCT03897127 Comparator Sep 2019 → Jun 2027 expected acute myeloid leukemia University of Ulm
Active not recruiting
No outcome recorded
Phase 3
NCT04043494 Background Aug 2019 → Apr 2030 expected lymphoblastic lymphoma University Hospital Muenster
Recruiting
No outcome recorded
Phase 3
NCT03512197 Background Jul 2018 → Feb 2021 acute myeloid leukemia Novartis Pharmaceuticals
Completed
No outcome recorded
Phase 3
NCT03643276 Background Jul 2018 → Jul 2028 expected childhood acute lymphoblastic leukemia Martin Schrappe
Recruiting
No outcome recorded
Phase 3
NCT03416179 Background Apr 2018 → Jun 2020 acute myeloid leukemia Pfizer
Completed
No outcome recorded
Phase 3
NCT03379727 Background Feb 2018 → Jul 2021 acute myeloid leukemia Novartis Pharmaceuticals
Completed
No outcome recorded
Phase 3
NCT03150693 Background Sep 2017 → Mar 2027 expected B-cell acute lymphoblastic leukemia Alliance for Clinical Trials in Oncology
Recruiting
No outcome recorded
Phase 3
NCT03257241 Comparator Jul 2017 → Apr 2022 acute myeloid leukemia Polish Adult Leukemia Group
Unknown
No outcome recorded
Phase 3
NCT03021330 Comparator Feb 2017 → May 2026 overdue acute myeloid leukemia Institute of Hematology & Blood Diseases Hospital, China
Active not recruiting
No outcome recorded
Phase 3
NCT02668653 Background Sep 2016 → Aug 2021 acute myeloid leukemia Daiichi Sankyo
Completed
No outcome recorded
Phase 3
NCT02881086 Background Aug 2016 → Dec 2024 acute lymphoblastic leukemia , lymphoblastic lymphoma Goethe University
Completed
No outcome recorded
Phase 3
NCT02665065 Comparator Jun 2016 → Jun 2022 overdue acute myeloid leukemia Actinium Pharmaceuticals
Active not recruiting
No outcome recorded
Phase 3
NCT02393859 Comparator Nov 2015 → Jul 2019 acute lymphoblastic leukemia Amgen
Completed
No outcome recorded
Phase 3
NCT02172872 Comparator Nov 2014 → Mar 2022 acute myeloid leukemia European Organisation for Research and Treatment of Cancer - EORTC
Unknown
No outcome recorded
Phase 3
NCT02112916 Background Oct 2014 → Mar 2020 overdue T-cell childhood acute lymphocytic leukemia , T-cell childhood lymphoblastic lymphoma National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 3
NCT02013648 Background Jul 2014 → Feb 2024 acute myeloid leukemia University of Ulm
Completed
No outcome recorded
Phase 3
NCT02003222 Background May 2014 → Jun 2023 overdue B-cell acute lymphoblastic leukemia National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 3
NCT02140242 Comparator Apr 2014 → Apr 2022 acute myeloid leukemia Technical University Dresden
Completed
No outcome recorded
Phase 3
NCT01696084 Comparator Dec 2012 → Dec 2015 acute myeloid leukemia Jazz Pharmaceuticals
Completed
No outcome recorded
Phase 3
NCT02883049 Background Feb 2012 → Dec 2022 B-lymphoblastic leukemia/lymphoma, BCR-ABL1–like , central nervous system leukemia , testicular leukemia National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 3
NCT01371981 Background Jul 2011 → Mar 2019 myeloid sarcoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 3
NCT02085408 Comparator Feb 2011 → Feb 2021 acute erythroid leukemia , acute megakaryoblastic leukemia in adult , acute myeloblastic leukemia with maturation , acute myeloblastic leukemia without maturation +9 ECOG-ACRIN Cancer Research Group
Completed
No outcome recorded
Phase 3
NCT00703820 Comparator Aug 2008 → Mar 2017 acute myeloid leukemia St. Jude Children's Research Hospital
Completed
No outcome recorded
Phase 3
NCT00671034 Background Jul 2008 → Feb 2011 B-cell adult acute lymphocytic leukemia , B-cell childhood acute lymphoblastic leukemia Children's Oncology Group
Completed
No outcome recorded
Phase 3
NCT00651261 Background Apr 2008 → Jul 2016 leukemia Alliance for Clinical Trials in Oncology
Unknown
No outcome recorded
Phase 3
NCT00557193 Background Jan 2008 → Sep 2017 T-cell childhood acute lymphocytic leukemia , acute undifferentiated leukemia Children's Oncology Group
Completed
No outcome recorded
Phase 3
NCT00927498 Comparator Dec 2007 → Jul 2011 acute myeloid leukemia Acute Leukemia French Association
Completed
No outcome recorded
Phase 3
NCT00549848 Background Oct 2007 → Sep 2020 acute lymphoblastic leukemia St. Jude Children's Research Hospital
Completed
No outcome recorded
Phase 3
NCT00715637 Comparator Jun 2007 → Jun 2010 acute myeloid leukemia Antisoma Research
Unknown
No outcome recorded
Phase 3
NCT00408005 Background Jan 2007 → Sep 2017 T-cell acute lymphoblastic leukemia , T-lymphoblastic lymphoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 3
NCT00372593 Background Aug 2006 → Aug 2013 leukemia Children's Oncology Group
Completed
No outcome recorded
Phase 3
NCT00275106 Background Sep 2004 → Dec 2009 lymphoma Children's Cancer and Leukaemia Group
Terminated
No outcome recorded
Phase 3
NCT00085709 Comparator Jul 2004 → Mar 2010 leukemia SWOG Cancer Research Network
Completed
No outcome recorded
Phase 3
NCT00075725 Background Dec 2003 → Dec 2010 B-cell adult acute lymphocytic leukemia , B-cell childhood acute lymphoblastic leukemia Children's Oncology Group
Completed
No outcome recorded
Phase 3
NCT00085124 Background Dec 2003 → Jun 2007 acute myeloid leukemia with 11q23 abnormalities , acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) , acute myeloid leukemia with t(8;21)(q22;q22) translocation National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 3
NCT00022737 Background Oct 2002 → Oct 2006 childhood acute lymphoblastic leukemia National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 3
NCT00046930 Background Sep 2002 → Jun 2009 myelodysplastic syndrome , myeloid leukemia Eastern Cooperative Oncology Group
Completed
No outcome recorded
Phase 3
NCT00131027 Background Sep 2002 → Mar 2011 acute lymphoblastic leukemia Japan Adult Leukemia Study Group
Unknown
No outcome recorded
Phase 3
NCT00136084 Background Aug 2002 → Jul 2008 acute myeloid leukemia St. Jude Children's Research Hospital
Completed
No outcome recorded
Phase 3
NCT00589082 Comparator Oct 2001 → Nov 2005 acute myeloid leukemia GIMEMA Foundation
Completed
No outcome recorded
Phase 3
NCT00006363 Background Nov 2000 → Jun 2005 acute basophilic leukemia , acute megakaryoblastic leukemia in adult , acute myeloblastic leukemia with maturation , acute myeloblastic leukemia without maturation +12 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 3
NCT00931138 Comparator Dec 1999 → Dec 2006 acute myeloid leukemia Acute Leukemia French Association
Completed
No outcome recorded
Phase 3
NCT00019409 Background Oct 1999 → Jul 2001 leukemia National Institutes of Health Clinical Center (CC)
Withdrawn
No outcome recorded
Phase 3
NCT00004128 Background Sep 1999 → Jan 2008 leukemia European Organisation for Research and Treatment of Cancer - EORTC
Unknown
No outcome recorded
Phase 3
NCT00003934 Background Jun 1999 → Nov 2006 acute myeloid leukemia, t(15;17)(q24;q21) , acute promyelocytic leukemia , childhood acute myeloid leukemia National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 3
NCT00266136 Background Jun 1999 → Jan 2007 acute myeloid leukemia University Hospital Muenster
Completed
No outcome recorded
Phase 3
NCT00003728 Background Dec 1998 → May 2008 leukemia , lymphoma European Organisation for Research and Treatment of Cancer - EORTC
Unknown
No outcome recorded
Phase 3
NCT00003190 Background Jan 1998 → Aug 2002 acute erythroid leukemia , acute megakaryoblastic leukemia in adult , acute myeloblastic leukemia with maturation , acute myeloblastic leukemia without maturation +8 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 3
NCT00003437 Background Jan 1997 → ? leukemia Medical Research Council
Unknown
No outcome recorded
Phase 3
NCT00002812 Background Sep 1996 → Mar 2006 acute leukemia Children's Oncology Group
Completed
No outcome recorded
Phase 3
NCT00002744 Background May 1996 → Mar 2007 leukemia Children's Oncology Group
Completed
No outcome recorded
Phase 3
NCT00002766 Comparator Mar 1996 → Sep 2011 leukemia , lymphoma Memorial Sloan Kettering Cancer Center
Completed
No outcome recorded
Phase 3
NCT00002700 Background Aug 1995 → Mar 2004 acute leukemia , lymphoma European Organisation for Research and Treatment of Cancer - EORTC
Completed
No outcome recorded
Phase 3
NCT00002514 Background May 1993 → Dec 2006 leukemia Eastern Cooperative Oncology Group
Completed
No outcome recorded
Phase 3
NCT00002517 Background Mar 1993 → May 2010 leukemia , myelodysplastic syndrome European Organisation for Research and Treatment of Cancer - EORTC
Completed
No outcome recorded
Show 69 more trials Phase 4 7 trials
Phase 4
NCT06289673 Background Dec 2024 → May 2034 expected acute lymphoblastic leukemia , lymphoblastic lymphoma , mixed phenotype acute leukemia St. Jude Children's Research Hospital
Recruiting
No outcome recorded
Phase 4
NCT07561892 Background Apr 2022 → Dec 2026 expected acute myeloid leukemia , chemotherapy-induced toxicity Fujian Medical University Union Hospital
Recruiting
No outcome recorded
Phase 4
NCT03026842 Comparator Jan 2017 → Dec 2023 acute myeloid leukemia The First Hospital of Jilin University
Unknown
No outcome recorded
Phase 4
NCT01191541 Background May 2010 → Feb 2017 leukemia Xiaofan Zhu
Completed
No outcome recorded
Phase 4
NCT01587430 Comparator Jan 2010 → Apr 2014 acute myeloid leukemia National Research Center for Hematology, Russia
Unknown
No outcome recorded
Phase 4
NCT00199004 Background Apr 2004 → Mar 2009 adult acute lymphoblastic leukemia Johann Wolfgang Goethe University Hospital
Completed
No outcome recorded
Phase 4
NCT00198991 Background Apr 2003 → Jun 2011 adult acute lymphoblastic leukemia Goethe University
Completed
No outcome recorded
Show 2 more trials Phase not applicable 7 trials
— NCT07454226 Background May 2026 → Mar 2028 expected acute lymphoblastic leukemia , phosphohydroxylysinuria Institute of Hematology & Blood Diseases Hospital, China
Recruiting
No outcome recorded
— NCT06841952 Comparator Feb 2025 → Dec 2028 expected acute myeloid leukemia The First Affiliated Hospital of Soochow University
Not yet recruiting
No outcome recorded
— NCT06529250 Comparator Aug 2024 → Aug 2026 overdue acute myeloid leukemia Institute of Hematology & Blood Diseases Hospital, China
Recruiting
No outcome recorded
— NCT05832320 Comparator Jan 2023 → Dec 2024 acute promyelocytic leukemia Peking University People's Hospital
Unknown
No outcome recorded
— NCT03446638 Comparator May 2019 → Aug 2021 myelodysplastic syndrome University of Florida
Withdrawn
No outcome recorded
— NCT03390387 Comparator Nov 2015 → Nov 2020 childhood acute lymphoblastic leukemia Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Unknown
No outcome recorded
— NCT00016302 Background Apr 2001 → Jul 2007 T-cell childhood acute lymphocytic leukemia National Cancer Institute (NCI)
Completed
No outcome recorded
Show 2 more trials Phase not stated 1 trial
— NCT01085617 Background Dec 2010 → Feb 2025 leukemia , mouth disorder , mucositis University College, London
Completed
No outcome recorded